Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

71
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
71
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

1.9K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.9K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

289
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
289
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

210
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
210
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

399
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
399

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathophysiology-driven neuroimaging: decoding brain injury in sepsis.

Frontiers in molecular neuroscience·2026
Same author

Inorganic nanomaterials empowering bacteria: a new paradigm for biomedical applications.

Journal of materials chemistry. B·2026
Same author

Nano-micro Combination: Overcoming Dual Intranasal Barriers to Elicit a Comprehensive Immune Response.

ACS applied materials & interfaces·2026
Same author

Tumor-Targeted Delivery Therapy Based on PLGA Nanoparticles.

Journal of functional biomaterials·2026
Same author

Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic Function.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment.

Biomaterials·2026

Related Experiment Video

Updated: Mar 9, 2026

Nanosponge Tunability in Size and Crosslinking Density
11:15

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

8.2K

Adjuvanticity Regulation by Biodegradable Polymeric Nano/microparticle Size.

Jilei Jia1,2, Weifeng Zhang1,2, Qi Liu1,2

  • 1State Key Laboratory of Biochemical Engineering, PLA Key Laboratory of Biopharmaceutical Production & Formulation Engineering, Institute of Process Engineering, Chinese Academy of Sciences , Beijing 100190, PR China.

Molecular Pharmaceutics
|January 4, 2017
PubMed
Summary

The optimal size for poly(lactic-co-glycolic acid) (PLGA) nanoparticles as vaccine adjuvants is 900 nm. These particles enhance immune cell uptake, activation, and antigen presentation, leading to superior humoral and cellular immune responses.

Keywords:
PLGA nano/microparticlesadjuvanticityparticle sizevaccine delivery

More Related Videos

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization
10:06

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization

Published on: September 2, 2022

2.4K
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
08:51

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Published on: March 1, 2013

16.8K

Related Experiment Videos

Last Updated: Mar 9, 2026

Nanosponge Tunability in Size and Crosslinking Density
11:15

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

8.2K
Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization
10:06

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization

Published on: September 2, 2022

2.4K
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
08:51

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Published on: March 1, 2013

16.8K

Area of Science:

  • Biomaterials Science
  • Immunology
  • Nanotechnology

Background:

  • Polymeric nanoparticles are investigated as vaccine adjuvants.
  • Understanding physicochemical properties, particularly size, is crucial for optimizing immune responses.

Purpose of the Study:

  • To investigate the effect of poly(d,l-lactic-co-glycolic acid) (PLGA) nanoparticle size on immune cell activation, antigen uptake, and vaccine adjuvanticity.
  • To determine the optimal PLGA nanoparticle size for enhancing both humoral and cellular immunity.

Main Methods:

  • Preparation of PLGA nanoparticles in uniform sizes (500 nm, 900 nm, 2.1 μm, 4.9 μm).
  • Evaluation of particle uptake kinetics, macrophage activation (NO, IL-1β secretion), and antigen internalization in vitro.
  • Assessment of adjuvanticity in vivo, measuring antibody protection, and secretion of IFN-γ and IL-4.

Main Results:

  • 900 nm PLGA nanoparticles showed the highest cellular accumulation and facilitated antigen internalization.
  • These particles effectively activated macrophages, inducing nitric oxide (NO) and interleukin-1β (IL-1β) secretion.
  • In vivo studies demonstrated that 900 nm particles provided superior adjuvanticity, eliciting the strongest antibody responses and highest levels of IFN-γ and IL-4.

Conclusions:

  • 900 nm is identified as the optimal size for PLGA nanoparticle-based vaccine adjuvants, particularly for recombinant antigens.
  • Particle size significantly influences immune responses, offering critical insights for rational vaccine design and development.